全外显子组测序揭示BCL2断裂阳性与阴性滤泡性淋巴瘤之间的差异
本研究对28例t(14;18)阳性和13例t(14;18)阴性滤泡性淋巴瘤进行外显子单核苷酸变异分析,并整合拷贝数改变、拷贝中性LOH及已发表基因表达数据。结果显示t(14;18)阴性FL同样携带典型FL突变,但免疫应答和N-糖基化特征更突出或独有,N-糖基化位点检出频率明显更低。
要点
- t(14;18)阴性FL也携带典型FL相关基因突变。
- t(14;18)阴性FL中免疫应答和N-糖基化基因集富集更突出或独有。
- t(14;18)阴性FL中N-糖基化位点检出频率明显更低。
核心结论
- 结果提示t(14;18)阴性FL存在多样化的遗传改变组合,可能诱导或调节BCL2表达或促进其发病。
- t(14;18)阴性FL可能通过与微环境更广泛但特异性较低的相互作用来补偿N-糖基化的缺乏。
研究设计与样本
- 研究分析了28例t(14;18)阳性和13例t(14;18)阴性滤泡性淋巴瘤的外显子单核苷酸变异谱。
- 研究整合了拷贝数改变、拷贝中性LOH、已发表基因表达数据以及免疫球蛋白N-糖基化位点评估。
主要发现
- 典型FL突变也影响t(14;18)阴性FL。
- 对t(14;18)阳性或阴性FL中突变基因进行 curated 基因集/通路注释显示相同或相似基因集强烈富集,但t(14;18)阴性FL中免疫应答和N-糖基化特征富集更突出或独有。
- 两个亚组中突变基因均显示与BCL2高度相关。
- t(14;18)阴性FL中突变的基因有555个受拷贝数改变和/或拷贝中性LOH影响,96个在t(14;18)阳性和阴性FL之间差异表达(P<0.01)。
- t(14;18)阴性FL中N-糖基化位点检出频率明显更低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Depending on disease stage follicular lymphoma (FL) lack the t(14;18) in ~15-~50% of cases. Nevertheless, most of these cases express BCL2. To elucidate mechanisms triggering BCL2 expression and promoting pathogenesis in t(14;18)-negative FL, exonic single-nucleotide variant (SNV) profiles of 28 t(14;18)-positive and 13 t(14;18)-negative FL were analyzed, followed by the integration of copy-number changes, copy-neutral LOH and published gene-expression data as well as the assessment of immunoglobulin N-glycosylation sites. Typical FL mutations also affected t(14;18)-negative FL. Curated gene set/pathway annotation of genes mutated in either t(14;18)-positive or t(14;18)-negative FL revealed a strong enrichment of same or similar gene sets but also a more prominent or exclusive enrichment of immune response and N-glycosylation signatures in t(14;18)-negative FL. Mutated genes showed high BCL2 association in both subgroups. Among the genes mutated in t(14;18)-negative FL 555 were affected by copy-number alterations and/or copy-neutral LOH and 96 were differently expressed between t(14;18)-positive and t(14;18)-negative FL (P<0.01). N-glycosylation sites were detected considerably less frequently in t(14;18)-negative FL. These results suggest a diverse portfolio of genetic alterations that may induce or regulate BCL2 expression or promote pathogenesis of t(14;18)-negative FL as well as a less specific but increased crosstalk with the microenvironment that may compensate for the lack of N-glycosylation.
引用
- Zamò A, Pischimarov J, Schlesner M, et al. Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing. Leukemia. 2017. PMID: 28824170. doi:10.1038/leu.2017.270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。